Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

A Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects

Participants needed: 76
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: China National Biotec Group Company LimitedUpdated: Jan 29, 2026Locations: 1
Eligibility criteria

Subjects voluntarily participate in the study, sign the informed consent form, a... [+3]

Subjects with a known allergy to Tecovirimat drugs, any excipient ingredients in... [+22]

Status: Not yet recruiting

the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

This study evaluated the antibody persistence of Chinese children five years after they received four doses of sIPV, two doses of MMR vaccine and one dose of HepA-L vaccine.

Participants needed: 600
Trial details
Biological sex: AllType: ObservationalSponsor: China National Biotec Group Company LimitedUpdated: Jan 14, 2026Locations: 6
Eligibility criteria

Participants in the NCT04638985 or NCT04636827, and who have completed the vacci... [+2]

None.